FDA Is ‘Getting More Aggressive’ In Going After Drug Efficacy Claims Outside Label

FDA investigation
FDA is giving greater scrutiny to prescription drug promotions that overstate efficacy • Source: Shutterstock

More from Marketing & Advertising

More from Compliance